Cargando…
Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment
The use of low doses of radium-224 ((224)Ra) chloride for the treatment of ankylosing spondylitis was stopped following the discovery that patients treated with it had a higher than control incidence of leukaemia and other cancers. This was so even though the treatment resulted in decreased pain and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192484/ https://www.ncbi.nlm.nih.gov/pubmed/32353063 http://dx.doi.org/10.1371/journal.pone.0232597 |